Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Brinkmalm

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Neuroscience|December 12, 2018
A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's DiseaseAnnika Öhrfelt, Ann Brinkmalm, Julien Dumurgier, et al.
Brain : a Journal of Neurology|November 22, 2023
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brainsMarc James Quesnel, Anne Labonté, Cynthia Picard, et al.
Multiple Sclerosis and Related Disorders|May 13, 2022
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot studyKalle Johansson, Pontus Wasling, Lenka Novakova, et al.
Journal of the Neurological Sciences|September 19, 2025
Low synaptic and neurosecretory proteins in cerebrospinal fluid in early parkinsonian diseaseProtik Jakobsson, Johanna Nilsson, Maria Nygren, et al.
Journal of Neurology|November 2, 2023
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasiaImogen J Swift, Simon Sjödin, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2024
Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's DiseaseFlora H Duits, Johanna Nilsson, Henrik Zetterberg, et al.
Alzheimer'S Research & Therapy|September 16, 2019
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's diseaseSimon Sjödin, Gunnar Brinkmalm, Annika Öhrfelt, et al.
Neurology|June 27, 2020
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer diseaseMarion Tible, Åsa Sandelius, Kina Höglund, et al.
Molecular Psychiatry|January 18, 2025
Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer's diseaseJiarui Ao, Cynthia Picard, Daniel Auld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's diseaseMarc James Quesnel, Anne Labonté, Cynthia Picard, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Neuroscience|December 12, 2018
A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's DiseaseAnnika Öhrfelt, Ann Brinkmalm, Julien Dumurgier, et al.
Brain : a Journal of Neurology|November 22, 2023
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brainsMarc James Quesnel, Anne Labonté, Cynthia Picard, et al.
Multiple Sclerosis and Related Disorders|May 13, 2022
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot studyKalle Johansson, Pontus Wasling, Lenka Novakova, et al.
Journal of the Neurological Sciences|September 19, 2025
Low synaptic and neurosecretory proteins in cerebrospinal fluid in early parkinsonian diseaseProtik Jakobsson, Johanna Nilsson, Maria Nygren, et al.
Journal of Neurology|November 2, 2023
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasiaImogen J Swift, Simon Sjödin, Johan Gobom, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2024
Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's DiseaseFlora H Duits, Johanna Nilsson, Henrik Zetterberg, et al.
Alzheimer'S Research & Therapy|September 16, 2019
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's diseaseSimon Sjödin, Gunnar Brinkmalm, Annika Öhrfelt, et al.
Neurology|June 27, 2020
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer diseaseMarion Tible, Åsa Sandelius, Kina Höglund, et al.
Molecular Psychiatry|January 18, 2025
Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer's diseaseJiarui Ao, Cynthia Picard, Daniel Auld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's diseaseMarc James Quesnel, Anne Labonté, Cynthia Picard, et al.
Pageof 7